BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19635671)

  • 1. Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV.
    Abdülkadir Coban T; Beydemir S; Gülcin I; Ekinci D; Innocenti A; Vullo D; Supuran CT
    Bioorg Med Chem; 2009 Aug; 17(16):5791-5. PubMed ID: 19635671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1583-7. PubMed ID: 18242985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.
    Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2008 Aug; 16(15):7424-8. PubMed ID: 18579385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.
    Yoo J; Thai KM; Kim DK; Lee JY; Park HJ
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4271-4. PubMed ID: 17553682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions.
    Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1855-7. PubMed ID: 19269822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Innocenti A; Mastrolorenzo A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4866-72. PubMed ID: 17588751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
    De Young L; Yu D; Freeman D; Brock GB
    Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.
    Bunnage ME; Mathias JP; Wood A; Miller D; Street SD
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6033-6. PubMed ID: 18951784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluations of sildenafil analogues for treatment of erectile dysfunction.
    Flores Toque HA; Priviero FB; Teixeira CE; Perissutti E; Fiorino F; Severino B; Frecentese F; Lorenzetti R; Baracat JS; Santagada V; Caliendo G; Antunes E; De Nucci G
    J Med Chem; 2008 May; 51(9):2807-15. PubMed ID: 18393409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
    Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.
    Innocenti A; Vullo D; Pastorek J; Scozzafava A; Pastorekova S; Nishimori I; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1532-7. PubMed ID: 17257840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
    Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
    Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
    Riafrecha LE; Rodríguez OM; Vullo D; Supuran CT; Colinas PA
    Bioorg Med Chem; 2013 Mar; 21(6):1489-94. PubMed ID: 23010455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI.
    Winum JY; Montero JL; Vullo D; Supuran CT
    Chem Biol Drug Des; 2009 Dec; 74(6):636-9. PubMed ID: 19824891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
    Boyle CD; Xu R; Asberom T; Chackalamannil S; Clader JW; Greenlee WJ; Guzik H; Hu Y; Hu Z; Lankin CM; Pissarnitski DA; Stamford AW; Wang Y; Skell J; Kurowski S; Vemulapalli S; Palamanda J; Chintala M; Wu P; Myers J; Wang P
    Bioorg Med Chem Lett; 2005 May; 15(9):2365-9. PubMed ID: 15837326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.